The Lancet Neurology in conversation with
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
Episodes
182 episodes
Florian Krismer and Elizabeth Coon on multiple system atrophy
Florian Krismer (Innsbruck Medical University) and Elizabeth Coon (Mayo Clinic) join Sarah Passey (The Lancet Neurology) to discuss their Review paper on multiple system atrophy, which is published in the December issue of The Lanc...
•
17:14
Suvankar Pal on the motor neuron disease trial MND-SMART
Professor Suvankar Pal (University of Edinburgh) joins Sarah Passey (Senior Editor at The Lancet Neurology) to discuss the first findings from the MND-SMART trial of treatments for motor neuron disease. The Article is published in the ...
•
17:50
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
Prof Jorge Correale and Dr Lilyana Amezcua talk to The Lancet Neurology about their Personal View papers, published in the October 2024 issue, on the differential diagnosis of multiple sclerosis in regions outside North America and Wes...
•
19:00
Alex Iranzo on sleep and Parkinson's disease
Dr Alex Iranzo joins The Lancet Neurology to discuss his recent Review on the association between sleep disorders and Parkinson's disease. The Review is published in the August issue of The Lancet Neurology.Read the fu...
•
16:44
Adrian Owen on detecting awareness after acute brain injury
Dr Adrian Owen joins Sarah Passey to chat about a his Personal View, published in the August 2024 issue of The Lancet Neurology, about detecting awareness after an acute brain injury.
•
17:19
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
Dr Glenn Nielsen joins Lauren Southwell to discuss the Physio4FMD trial of specialist physiotherapy for people with functional motor disorder in England and Scotland. This Article is published in the July issue of The Lancet Neurology....
•
15:28
Sanjay Sisodiya on climate change and brain health
Sanjay Sisodiya joins The Lancet Neurology to discuss the potential effects of climate change on brain health. The Personal View is published in the June issue of The Lancet Neurology.
•
20:48
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
Jacqueline French and Jacob Pellinen join Senior Editor Sarah Passey to discuss recent progress made in the diagnosis of epilepsy and challenges that remain. Their Review on this topic is published in the May issue of The Lancet Neurology
•
23:28
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
Jaimie Steinmetz and Theo Vos from the Institute for Health Metrics and Evaluation, and Katrin Seeher and Tarun Dua from WHO, join Heather Brown and Lauren Southwell to discuss new data on the global, regional, and national burden of disorders ...
•
25:18
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
Giovanni Frisoni joins The Lancet Neurology to discuss new European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. The Personal View is published in the March issue of The Lancet Neurol...
•
12:20
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
Marianne Chapleau and Gil Rabinovici join Senior Editor Sarah Passey to discuss their research on posterior cortical atrophy. The Article is published in the February issue of The Lancet Neurology.Read the full article:
•
21:45
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
Cecilia Åkerlund and David Nelson join The Lancet Neurology to discuss their research on clinical variables that might distinguish how the disease process progresses in people with traumatic brain injury. The Article is published in th...
•
18:24
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
Rustam Al-Shahi Salman joins Senior Editor Sarah Passey to discuss the COCROACH meta-analysis findings, published in the December issue of The Lancet Neurology, of the effects of oral anticoagulation in people with atrial fibrillation ...
•
24:09
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations
Njideka Okubadejo and Mie Rizig join The Lancet Neurology to discuss their comprehensive genome-wide assessment in African and African admixed individuals with the aim of developing a better understanding of the genetic architectu...
•
26:34
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple s...
•
14:42
William Jagust on amyloid β and cognition
William Jagust (University of California in Berkeley, CA, USA) talks to Senior Editor Sarah Passey about the complex pathway between amyloid β and cognition, and implications for therapy for people with Alzheimer’s disease. His Personal View on...
•
13:36
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
Stephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patients with chronic cervical spinal cord injury. The Article is published in the August issue of ...
•
14:34
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
Benzi Kluger (University of Rochester Medical Center, Rochester, NY, USA), Claire Creutzfeldt (University of Washington, Seattle, WA, USA), and Malenna Sumrall (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) join Jonathan Blot...
•
17:20
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
Andrew Cole (Massachusetts General Hospital Epilepsy Service, Boston, MA, USA) talks to Senior Editor Sarah Passey about the complexities underlying epilepsy in people with glioblastoma. His Review on this topic is published in the June issue o...
•
18:38
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
Karen Duff and Connor Langworth-Green (University College London, London, UK) discuss tauopathies and the chronic effects of inflammation on this group of disorders. Their Personal View on this topic is published in the May issue of The Lan...
•
15:20
Kerstin Hellwig on family planning considerations in MS
Kerstin Hellwig (Ruhr University Bochum, Bochum, Germany) discusses family planning considerations in multiple sclerosis. This Review is published in the April issue of The Lancet Neurology.
•
14:24
Geraldine Dawson on advances in the prediction of autism during infancy
Geraldine Dawson (Duke University School of Medicine, NC, USA ) discusses the latest advances and ongoing challenges in prediction of autism during infancy. This Review is published in the March issue of The Lancet Neurology.Re...
•
24:34
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatmen...
•
8:45
Beau Ances on amyloid biomarkers in Alzheimer’s
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology....
•
11:34
Axel Petzold on the diagnosis and classification of optic neuritis
Axel Petzold (National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, London, UK, and Amsterdam University Medical Center, Amsterdam, Netherlands) discusses a Position Paper, published in the December issue of The Lancet N...
•
20:03